Happy you've got it all wrong. It is AZ's trial with AZ's drug. SPL have provided Dep and it's the Dep part which is touted to bring in the $2.4B which to me is just typical JF fairy tale talk just like the $1.75B BV market where we appear to have cornered a couple of hundred thousand max of that which they will not disclose. They won't disclose how much income is coming from BV treatment because she claims it's commercially sensitive. What BS!
The only reason it's "commercially sensitive" is because it's an embarrassment.
SPL Price at posting:
93.0¢ Sentiment: Hold Disclosure: Held
